W. Mehnert - Concepedia

Author

W. Mehnert

Freie Universität Berlin

Also Known As

D Bellmann, Mehnert, Wolfgang, W MEHNERT, W Mehnert, W. MEHNERT, W. Mehnert, Wolfgang Mehnert

Publications

10.6K

Citations

H-Index

Concepts

All Affiliations

Freie Universität Berlin Ludwig-Maximilians-Universität München Charité - Universitätsmedizin Berlin Martin Luther University Halle-Wittenberg University of Bonn

About

W. Mehnert is an author at Freie Universität Berlin specializing in engineering, pharmacology, and nanoparticles.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	13	15	4.3K
2	Medicine	9	9	1.6K
3	Natural Sciences	9	9	463
4	Applied Physics	3	3	38
5	Health Sciences	2	2	201

W. Mehnert

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism A. zur Mühlen, C. Schwarz, W. Mehnert European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineEngineeringNanomaterialsMedicine	1998	927
Solid lipid nanoparticles W. Mehnert, Karsten Mäder Advanced Drug Delivery Reviews NanoparticlesLipid PreparationEngineeringNanomaterialsSolid Lipid Nanoparticles	2012	899
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization C. Schwarz, W. Mehnert, J.S. Lucks, Journal of Controlled Release NanoparticlesNanomedicineEngineeringSolid Lipid NanoparticlesPharmaceutical Nanotechnology	1994	564
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy Katja Jores, W. Mehnert, Markus Drechsler, Journal of Controlled Release NanoparticlesLipid PreparationEngineeringNanomaterialsNanotechnology	2004	463
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery R.H. Müller, W. Mehnert, J.S. Lucks, European Journal of Pharmaceutics and Biopharmaceutics	1995	456
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals Rainer Müller, Stephan Runge, Vitale Ravelli, International Journal of Pharmaceutics NanoparticlesNanomedicineOral BioavailabilityEngineeringSolid Lipid Nanoparticles	2006	301
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant Rainer Müller, Dörte Rühl, Stephan Runge, Pharmaceutical Research	1997	263
Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy S. Lombardi Borgia, Martin Regehly, W. Mehnert, Journal of Controlled Release NanoparticlesNanomedicineEngineeringLipid NanoparticlesSkin Penetration Enhancement—correlation	2005	229
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN) C. Schwarz, W. Mehnert International Journal of Pharmaceutics NanoparticlesEngineeringNanomaterialsNano-drug DeliveryChemistry	1997	229
Phagocytic Uptake and Cytotoxicity of Solid Lipid Nanoparticles (SLN) Sterically Stabilized with Poloxamine 908 and Poloxamer 407 Ralph Müller, S. Maaβen, H Weyhers, Journal of drug targeting	1996	221

Page 1